chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting, Weight decreased
Clinical narrative: Dizzy; by the time I got up on tue. I had the shakes,; Nausea; when I tried to eat I threw up,; can feel my lymph nodes are slightly swollen,; as well as Joint pain,; Chills; Muscle pain; One day after the shot my arm felt like I had just received a tetnis shot. I got the shot 17 apr a sat. by monday I was feeling weak; Slept for 24 hours; Have eat on once since Sunday; Weight has dropped from 185 to 172.; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: 59267-1000-01) via an unspecified route of administration in the left arm on 17Apr2021 at 09:15 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included recovery from heroin addiction from past 26 months and allergy to penicillin and its relatives. Prior to the vaccination, the patient was not  diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included clindamycin (MANUFACTURER UNKNOWN) for unknown indication on unknown date and unknown if ongoing. On 19Apr2021, one day after the shot, the patient arm felt like receiving a tetanus shot and weak, so he layed down and slept for 24 hours. On 20Apr2021, the next day, by the time the patient got up experienced shakes, was dizzy, had nausea, when he tried to eat he threw up, lymph nodes were slightly swollen, as well as joint pain, chills, and muscle pain. On 21Apr2021, on the next day, it was worse. On 22Apr2021, after a day, the patient felt slightly better. The patient reported that he was in contact with doctor and was told to rest, take tylenol and if symptoms get worsened then to go to the emergency room. The patient was resting, but have eaten only once since 18Apr2021, the day after vaccine. The patient weight had dropped from 185 to 172 (unspecified units). The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm felt like had just received a tetanus shot and felt weak, layed down and slept for 24 hours, shakes, was dizzy, had nausea, threw up, lymph nodes slightly swollen, joint pain, chills, muscle pain and weight dropped from 185 to 172 (unspecified units) was resolved with sequelae on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling
Clinical narrative: Lips were swollen when she woke up and continued getting worse; This is a spontaneous report from contactable consumer. A female patient of an unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on 21Apr2021 as a single dose for COVID-19 immunisation. The patients' medical history was not reported. It was unknown if the patient was pregnant at the time of vaccination. It was unknown if the patient received any medications within two weeks prior to the COVID-19 vaccination. It was unknown if the patient received any other vaccines within four weeks prior to the COVID-19 vaccination. On 22Apr2021, the patient lips were swollen when she woke up and continued getting worse. The event resulted in emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the event. The clinical outcome of the event lips were swollen when she woke up and continued getting worse was unknown at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, Diarrhoea, Nausea
Clinical narrative: diarrhea, nausea, anemia; diarrhea, nausea, anemia; diarrhea, nausea, anemia; This is a spontaneous report from a contactable consumer (patient herself). A 77-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EN6207; Expiration date: unknown) via an unspecified route of administration, administered in Arm Left on 17Mar2021 10:00 (at age of 77-years-old) as DOSE 2, SINGLE for COVID-19 immunization. The patient was not pregnant at the time of vaccination. Medical history included hypertension, vascular stent stenosis, seasonal allergy from an unknown date and unknown if ongoing. Concomitant medications included losartan (LOSARTAN), metoprolol tartrate (METOPROLOL TARTRATE), fexofenadine hydrochloride (ALLEGRA), aspirin [acetylsalicylic acid] (ASPIRIN [ACETYLSALICYLIC ACID]) taken for an unspecified indication. The patient previously took cipro [ciprofloxacin], crestor, dulera and percocet [oxycodone hydrochloride;oxycodone terephthalate;paracetamol] and experienced drug hypersensitivity. Historical vaccine included first doe of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EN6203; Expiration date: unknown) via an unspecified route of administration, administered in Arm Left on 24Feb2021 10:00 (at age of 77-years-old) as DOSE 1, SINGLE for COVID-19 immunization. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 21Mar2021 the patient experienced diarrhea, nausea, anemia. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of diarrhea, nausea, anemia as patient had received treatment with omeprazole, benefiber and iron. Since the vaccination, patient has not been tested for COVID-19. The outcome of all events was not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Both legs swelled up from thighs through toes; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 09Apr2021 at 11:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to penicillin. The patient had known allergies to tetracycline hydrochloride (TETRACYCLINE). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vitamin d nos (VITAMIN D), calcium (MANUFACTURER UNKNOWN), aciclovir (ACYCLOVIR) and multivitamin (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 19Mar2021 at 14:45 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 18:30, approximately 24 hours after shot after a 5 hours car drive, the patient experienced both legs swelled up from thighs through toes and swelling lasted about 36 hours then started to return to normal. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with first lying down with legs above heart and that helped and also used ie on ankles which seemed to help. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event both legs swelled up from thighs through toes was recovered on 12Apr2021, after the duration of about 36 hours.   No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Pruritus
Clinical narrative: Stomach ache; Itchy arm; Chills; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 26Mar2021 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. On 17Apr2021, the patient experienced stomach ache, itchy arm and chills. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events stomach ache, itchy arm and chills were not recovered at the time of this report.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Lymphoedema, Pyrexia
Clinical narrative: lymphedema under arm, collarbone; Fatigue; Headache; Chills; Fever; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Apr2021 at 11:15 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 20Apr2021 at 11:15, the patient experienced lymphedema under arm and collarbone, fatigue, headache, chills and fever. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of reported events. The clinical outcome of the events lymphedema under arm and collarbone, fatigue, headache, chills and fever were unknown at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Inappropriate schedule of product administration, Myalgia, Pyrexia
Clinical narrative: Inappropriate schedule of vaccine administered- dose 1  28Mar2021; dose 2- 11Apr2021; Fever - 101 during first two days; muscle pain; muscle chill; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Apr2021 at 13:15 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Patient had no relevant medical history. The patient had no allergies to medications, food or any other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included paracetamol (TYLENOL) for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Mar2021 at 14:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation and experienced no side effects. The patient did not receive any other vaccines within four weeks prior to the vaccination. on 11Apr2021 patient experienced fever 101 (unspecified units) during first two days, muscle pain for one day and muscle chill for 5 days. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event muscle pain was recovered on 12Apr2021 after the duration of 1 day. The clinical outcome of the event fever - 101(unspecified units) was recovered on 13Apr2021 after the duration of 2 days. The clinical outcome of the event muscle chills was recovered on 16Apr2021 after the duration of 5 days.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain, Pyrexia
Clinical narrative: Chills; Body aches; Fever over 102.5; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0158) via an unspecified route of administration in the left arm on 21Apr2021 at 13:00 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included pseudoephedrine sulfate, loratadine (ALLERCLEAR D) 24hr and loratadine, pseudoephedrine sulfate (CLARITIN-D); both on unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: Er8732) via an unspecified route of administration in the left arm on 01Apr2021 at 12:15 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. The patient previously received pertussis vaccine (MANUFACTURER UNKNOWN) on unknown date for an unspecified indication and experienced allergy to vaccine. On 22Apr2021 at 15:00, the patient experienced chills, body aches and fever over 102.5. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On 22Apr2021 at 15:00, the patient underwent lab test and procedure which included body temperature and result was shown as 102.5 (units unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, body aches and fever over 102.5 were resolving at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Fist sized swollen gland near collar bone on right side.; This is a spontaneous report from a contactable healthcare professional, pharmacist. A 63-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an intramuscular route of administration in the right arm on 08Apr2021 at 12:00, (at the age of 63-years old) as a single dose for COVID-19 immunisation. The patient's medical history included diabetes and high cholesterol. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. Concomitant medications were not reported. It was unknown whether the patient had received any other vaccines within 4 weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an intramuscular route of administration in right arm on 18Mar2021 at 12:00, (at the age of 63-years old) as a single dose for COVID-19 immunisation. On 11Apr2021 at 12:00, few days after receiving the second dose, the patient had experienced fist sized swollen gland near collar bone on right side, which was resolved after about 4 days. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. No therapeutic measures were taken as a result of adverse events. The events did not result in doctors or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event, fist sized swollen gland near collar bone on right side was recovered on 15Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lymph node pain, Nausea, Neck mass
Clinical narrative: Swelling size in same area and also in back and under arm; Felt like ball in neck; Tired; Headache; Nausea; Body aches; Pain in neck lymph node area; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 19Apr2021 at 15:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included cervical cancer on an unknown date in 2012, fatty liver and high cholesterol. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included simvastatin (MANUFACTURER UNKNOWN) and vitamins  (unspecified) from an unknown date for an unknown indication and unknown if ongoing. The patient previously received first dose (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 25Mar2021 at 14:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 19:30, the patient experienced regular symptoms of tired, headache, nausea, and body aches until wednesday night where she felt pain in neck lymph node area, felt like ball in her neck. The patient fell asleep after taking diphenhydramine hydrochloride/paracetamol (TYLENOL PM). On 22Apr2021, the patient woke up with very apparent swelling size in the same area and also in back and under arm. The patient felt that it was enough to go to doctor for her concerns. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events body aches and pain in lymph node area which included treatment with diphenhydramine hydrochloride/paracetamol (TYLENOL PM). The clinical outcome of the events tired, headache, nausea, body aches, pain in neck lymph node area, felt like ball in neck and swelling size in same area and also in back and under arm were unknown at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Swelling
Clinical narrative: Swelling size in same area and also in back and under arm; Felt like ball in neck; Tired; Headache; Nausea; Body aches; Pain in neck lymph node area; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 19Apr2021 at 15:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included cervical cancer on an unknown date in 2012, fatty liver and high cholesterol. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included simvastatin (MANUFACTURER UNKNOWN) and vitamins  (unspecified) from an unknown date for an unknown indication and unknown if ongoing. The patient previously received first dose (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 25Mar2021 at 14:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 19:30, the patient experienced regular symptoms of tired, headache, nausea, and body aches until wednesday night where she felt pain in neck lymph node area, felt like ball in her neck. The patient fell asleep after taking diphenhydramine hydrochloride/paracetamol (TYLENOL PM). On 22Apr2021, the patient woke up with very apparent swelling size in the same area and also in back and under arm. The patient felt that it was enough to go to doctor for her concerns. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events body aches and pain in lymph node area which included treatment with diphenhydramine hydrochloride/paracetamol (TYLENOL PM). The clinical outcome of the events tired, headache, nausea, body aches, pain in neck lymph node area, felt like ball in neck and swelling size in same area and also in back and under arm were unknown at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: Arm soreness; Fever; Muscle pain; Joint pain; Fatigue; This is a spontaneous report from a contactable consumer. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 21Apr2021 at 10:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 (Prior to the vaccination, the patient was diagnosed with COVID-19). Concomitant medications included losartan (MANUFACTURER UNKNOWN), amlodipine (MANUFACTURER UNKNOWN), fluoxetine hydrochloride (PROZAC), multi vitamin and magnesium (MANUFACTURER UNKNOWN); all from an unknown date for unknown indication and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 30Mar2021 at 10:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 21Apr2021 at 12:00, the patient experienced arm soreness, fever, muscle pain, joint pain and fatigue. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of reported events which included treatment with paracetamol (TYLENOL). The clinical outcomes of event arm soreness, fever, muscle pain, joint pain and fatigue were resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Developed singles 2 days after first dose; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 14:30 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to nuts and shellfish. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN) for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 12:00, 2 days after first dose the patient developed shingles. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shingles was recovered with sequelae on an unknown date in Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Nausea, Pain, Pruritus
Clinical narrative: itches; felt nauseous upon waking; however, felt better after eating something; Body aches; Chilled/freezing; Redness around injection spot; Low-grade fever (99.8/99.2) (normal is 97.7); This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 19Apr2021 at 09:30 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure, cholesterol, meniere's disease, polycystic ovarian syndrome and drug allergy to sulfate, birth control medicines, also food sensitive but no allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), paracetamol (TYLENOL) and ibuprofen (ADVIL); all for an unknown indication from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 29Mar2021 at 09:30 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. On 20Apr2021, the patient felt nauseous upon waking; however, felt better after eating something.  Had low-grade fever (99.8/99.2) (normal is 97.7), body aches, temperature was 97.9 by the time made it to work.  Body aches continued throughout the day, was chilled. Turned heat up to 80 and was still freezing. The patient had redness around injection spot. On 21Apr2021, there were no body aches, redness was hot, firm, and itches from time to time.  On 22Apr2021, also there were no body aches. Called doctor office who asked to use cold compress, and take BENADRYL. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. As therapeutic measures the patient taken BENDARYL on 22Apr2021 at 1600 for redness. On 20Apr2021, patient body temperature was measured and result was 99.8/99.2(unit unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event body aches was resolved on 21Apr2021. The clinical outcome of the event redness around injection spot, chilled, low-grade fever, nauseous and itches was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema
Clinical narrative: itches; felt nauseous upon waking; however, felt better after eating something; Body aches; Chilled/freezing; Redness around injection spot; Low-grade fever (99.8/99.2) (normal is 97.7); This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 19Apr2021 at 09:30 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure, cholesterol, meniere's disease, polycystic ovarian syndrome and drug allergy to sulfate, birth control medicines, also food sensitive but no allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), paracetamol (TYLENOL) and ibuprofen (ADVIL); all for an unknown indication from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 29Mar2021 at 09:30 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. On 20Apr2021, the patient felt nauseous upon waking; however, felt better after eating something.  Had low-grade fever (99.8/99.2) (normal is 97.7), body aches, temperature was 97.9 by the time made it to work.  Body aches continued throughout the day, was chilled. Turned heat up to 80 and was still freezing. The patient had redness around injection spot. On 21Apr2021, there were no body aches, redness was hot, firm, and itches from time to time.  On 22Apr2021, also there were no body aches. Called doctor office who asked to use cold compress, and take BENADRYL. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. As therapeutic measures the patient taken BENDARYL on 22Apr2021 at 1600 for redness. On 20Apr2021, patient body temperature was measured and result was 99.8/99.2(unit unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event body aches was resolved on 21Apr2021. The clinical outcome of the event redness around injection spot, chilled, low-grade fever, nauseous and itches was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Angular cheilitis, Cheilitis, Lip pain, Oral discomfort
Clinical narrative: Corners of lips are inflamed; Corners of lips are painful; Burning sensation as well; Looks and feels like Angular cheilitis; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Apr2021 at 15:45 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021 the patient experienced corners of lips inflamed and painful and had burning sensation as well. It looked and felt like Angular cheilitis. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event corners of lips inflamed and painful, burning sensation as well and looked and felt like Angular cheilitis was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash macular, Skin exfoliation
Clinical narrative: Rash on hands.; Red and splotchy at first, not itchy; Then peeled.; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 08Apr2021 at 15:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any medications within two weeks of the COVID-19 vaccine. On 12Apr2021 at 08:00, the patient experienced rash on hands, red and splotchy at first, not itchy. Then peeled, still red. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash on hands, red and splotchy at first, not itchy. Then peeled, still red was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Gastroenteritis viral, Insomnia, Pyrexia
Clinical narrative: Fever; chills; insomnia; felt like had a stomach virus; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 (at the age of 19-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received other medications (unspecified) within 2 weeks prior to vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021(at the age of 19-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021 at 00:00 the patient experienced fever, chills, insomnia and felt like he had a stomach virus. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event fever, chills, insomnia and felt like he had a stomach virus was recovering at the time of report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Got shingles within 4 days of taking vaccine shot; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 14Apr2021 at 14:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Other medical history not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, within 4 days of taking vaccine shot, the patient experienced shingles. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shingles was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Full blood count, Pyrexia
Clinical narrative: Low-grade fever for fiveweeks, starting on the day of mysecond dose; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 19Mar2021 at 09:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included finasteride (PROPECIA) and doxycycline (MANUFACTURER UNKNOWN) from an unknown date for unknown indication and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number; EN6200) via an unspecified route of administration in the left arm on 26Feb2021 at 8:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. On 19Mar2021 at 18:00, the patient experienced a low-grade fever for five weeks, starting on the day of second dose. The patient reported that the fever was not subsided, that was highly unusual since the patient had no cold, flu, or fever of any sort in over 10 years and the patient was in overall excellent health. For the first 4.5 weeks, the patient took paracetamol (TYLENOL) to reduce the fever, but the fever would not fully go away. The patient doctor had a complete blood count (CBC) performed, and it detected nothing abnormal, in the last two days, doctor prescribed a course of prednisone (MANUFACTURER UNKNOWN) to counteract what thought might be an overactive immune response. In the first day of the course, fever was greatly increased, and so patient doctor told not to take any more prednisone and the fever remained. Since the vaccination, the patient had not been tested for COVID-19. The patient underwent lab tests and procedures on an unknown date in 2021, which included complete blood count (CBC) and the result was nothing abnormal. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of a low-grade fever for five weeks, which included treatment with paracetamol (TYLENOL) and prednisone (MANUFACTURER UNKNOWN) for one day. The clinical outcome of event a low-grade fever for five weeks was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Eczema, Lymphadenopathy, SARS-CoV-2 test, Skin warm
Clinical narrative: "corona arm" on the backs of legs and  left elbow. It appeared in places that regularly get eczema. The spot on  right leg was slightly bigger than hand (pretty big); The ones on legs now look bruised (purple with some broken blood vessels); Left lymph node did swell up in armpit; They were all raised slightly, were a little warm, and had a pale outline; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 19Apr2021 at 16:00 (at the age of 19-years-old), as a single dose for COVID-19 immunisation. Medical history included eczema. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included ibuprofen (ADVIL), chlorphenamine maleate (CHLOR-TRIMETON), loratadine (ALLERCLEAR) and cetirizine hydrochloride (ALLERTEC); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 29Mar2021 at 16:00 (at the age of 19-years-old), as a single dose for COVID-19 immunisation. On 13Apr2021, the patient underwent lab test and procedure which included SARS-CoV-2 Saliva PCT (SARS-CoV-2 test) and the result was negative. On 20Apr2021 at 22:45, the patient got what is commonly referred to as "corona arm" on the backs of the legs and left elbow. It appeared in places that the patient regularly get eczema. The spot on right leg was slightly bigger than the hand (pretty big), while the spot on the arm and left leg were closer to the size of a large lemon. They were all raised slightly, were a little warm, and had a pale outline. The ones on legs now look bruised (purple with some broken blood vessels). The patient had no rash around the site of injection, but the left lymph node did swell up in the armpit. They did not  hurt or itch, but they look bad. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events "corona arm" on the backs of legs and left elbow. It appeared in places that regularly get eczema. The spot on right leg was slightly bigger than hand (pretty big), the ones on legs now look bruised (purple with some broken blood vessels), left lymph node did swell up in armpit and they were all raised slightly, were a little warm, and had a pale outline were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Dizziness, Headache, Pain
Clinical narrative: Mild fever; chills; body aches; headache; dizzy; slight cough; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 22Apr2021 at 10:30 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. Medical history included sinus tachycardia. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN) 25 mg and cannabis sativa (CBD BROAD SPECTRUM TICNTURE) 1200mg; both for unspecified indication and start date. The patient previously took cefdinir (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 01Apr2021 at 10:00 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 17:00, the patient experienced mild fever, chills, body aches, headache, dizzy, slight cough. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events mild fever, chills, body aches, headache, dizzy, slight cough was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Mild fever; chills; body aches; headache; dizzy; slight cough; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 22Apr2021 at 10:30 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. Medical history included sinus tachycardia. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN) 25 mg and cannabis sativa (CBD BROAD SPECTRUM TICNTURE) 1200mg; both for unspecified indication and start date. The patient previously took cefdinir (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 01Apr2021 at 10:00 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 17:00, the patient experienced mild fever, chills, body aches, headache, dizzy, slight cough. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events mild fever, chills, body aches, headache, dizzy, slight cough was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Blister, Rash macular, Urticaria
Clinical narrative: Shingles-like rash primarily on the sides of my torso from lower hips up to shoulders with a few spots on my chest.; look like red hives about 3/4 to 1.5 inches across; white headed blister with mild pain and itch; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8743) via an unspecified route of administration in the left arm on 29Mar2021 at 08:30 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications in two weeks. The patient had no known allergies. On 14Apr2021, the patient experienced shingles-like rash primarily on the sides of his torso from lower hips up to shoulders with a few spots on his chest, looked like red hives about 3/4 to 1.5 inches across and then developed a white-headed blister with mild pain and itch. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shingles-like rash primarily on the sides of torso from lower hips up to shoulders with a few spots on chest, red hives about 3/4 to 1.5 inches across and white-headed blister with mild pain and itch was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.